lysaccharide Vaccine For Human
0.5ml/Vial
origin: China
packaging:
MOQ: 5000
China Meningococcal Polysaccharide Vaccine(quadrivalent) with High-Quality, Leading Meningococcal Polysaccharide Vaccine(quadrivalent) Manufacturers & Suppliers, find Meningococcal Polysaccharide Vaccine(quadrivalent) Factory & Exporters.
[Eligibles] Adults and children over two years of age. [Function and use] The vaccine is indicated for active immunization against invasive meningococcal disease caused by epidemic Neisseria meningitidis serogroups A,C,Y,W135. [Description] The vaccine is a preparation of preparation polysaccharide antigens extracted from the culture of Neisseria meningitidis group ACYW135 respectively and Iyophilized after addition of an appropriate stabilizer. The final product looks like a white crisp cake. It shall dissolve in the accompanying Phosphate buffered saline (PBS) immediately, and turn into a clear liquid after reconstitution. Active constituent: Neisseria meningitidis group ACYW135 capsular polysaccharides. Subsidiary materials: All the components of subsidiary materials approved shall be listed. Vaccine diluent: Sterile, pyrogen-free PBS. [Specifications] 0.5 ml of reconstituted vaccine per container. 0.5 ml per single human dose, containing 200μg of meningococcal polysaccharide (50μg of each polysaccharide of group A,C,Y,W135). [Feature] Fill a gap in our country for the first time by developing 4-valent vaccine . Improve traditional purification technology to eliminate nucleic acid and protein. Improve WHO specifications and high harvest rate. Develop new type of stabilizer. Improve national quality standards. 1.Group ACYW135 2.Group A+C 3.prevent epidemic cerebrospinal meningitis 4.purified capsular polysaccharide antigens http://www.ccls-vaccine.com
*Your email address will not be published. Required fields are marked.